Spine Biomechanics During Gait Following Lower Extremity Treatment in Different Patient Groups

NCT ID: NCT01803243

Last Updated: 2018-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measuring spine dynamics is a necessity in order to better understand gait deviations throughout the whole body and to evaluate treatment effects on spinal movement during gait. However, the full body marker sets that are typically used in opto-electronic 3D gait analyses either disregard the spine entirely or regard it as a rigid structure. Therefore, the purpose of this study is to use an enhanced trunk marker set in order to evaluate the biomechanical effects of lower extremity treatments on spine dynamics in patients with different pathologies.

It has been hypothesized that

1. the enhanced trunk marker set is a reliable method for the measurement of spine dynamics during gait in patients with deviations occurring secondary to leg length inequality.
2. the enhanced trunk marker set is a reliable method for the measurement of spine dynamics during gait in patients that present both primary and secondary deviations such as seen in hemiplegic and diplegic cerebral palsy.
3. treatment by means of either a shoe insole or a modified shoe with sole lift on the shorter side has an effect on spine dynamics during gait in patients with leg length inequality.
4. treatment by means of an ankle foot orthosis to control the foot position has an effect on spine dynamics during gait in patients with hemiplegic and diplegic cerebral palsy.

To verify the hypotheses, instrumented gait analyses with a standard full body marker set and the enhanced trunk marker set will be carried out before and immediately after an orthotic lower extremity treatment in the respective patient group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leg Length Inequality Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Leg length correction

The shorter leg in a sample of 15 patients with structural leg length inequality will be corrected by either a shoe insole or a modified shoe with sole lift.

Group Type EXPERIMENTAL

Shoe insole

Intervention Type OTHER

The heel of the shorter leg of the patient is lifted by a shoe insole. This procedure is commonly applied with leg length differences of up to 20mm.

Modified shoe with sole lift

Intervention Type OTHER

The heel of the shorter leg of the patient is lifted by building up the sole of the shoe (shoe sole lift). This procedure is commonly applied with leg length differences of 20mm and more.

Control of foot position 1

The foot position in in a sample of 15 patients with hemiplegic cerebral palsy will be controlled by an ankle foot orthosis.

Group Type EXPERIMENTAL

Ankle foot orthosis

Intervention Type OTHER

Ankle foot orthoses are a common treatment method to control the foot position during walking and to prevent ankle plantar flexion contractures in cerebral palsy patients.

Control of foot position 2

The foot position in in a sample of 15 patients with diplegic cerebral palsy will be controlled by an ankle foot orthosis.

Group Type EXPERIMENTAL

Ankle foot orthosis

Intervention Type OTHER

Ankle foot orthoses are a common treatment method to control the foot position during walking and to prevent ankle plantar flexion contractures in cerebral palsy patients.

Control

A sample of 15 healthy controls from a simultaneously conducted study (UKBB-Spine-1315-1) will be used for comparative purposes.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ankle foot orthosis

Ankle foot orthoses are a common treatment method to control the foot position during walking and to prevent ankle plantar flexion contractures in cerebral palsy patients.

Intervention Type OTHER

Shoe insole

The heel of the shorter leg of the patient is lifted by a shoe insole. This procedure is commonly applied with leg length differences of up to 20mm.

Intervention Type OTHER

Modified shoe with sole lift

The heel of the shorter leg of the patient is lifted by building up the sole of the shoe (shoe sole lift). This procedure is commonly applied with leg length differences of 20mm and more.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed structural leg length inequality (minimum 1% of body height)
* Several different aetiologies (except neurological)
* Able to walk a distance of minimum 50 meters without any assistive device


* Diagnosed hemiplegic cerebral palsy (Gross Motor Function Classification System for Cerebral Palsy (GMFCS): Levels I and II)
* Able to walk a distance of minimum 50 meters barefoot and without any assistive device


* Diagnosed diplegic cerebral palsy (Gross Motor Function Classification System for Cerebral Palsy (GMFCS): Levels I and II)
* Able to walk a distance of minimum 50 meters barefoot and without any assistive device

Exclusion Criteria

* Leg length inequality due to neurological aetiology
* Structural deformities of the spine
* Obesity (\> 95th BMI-per-age percentile)
* Injuries of the locomotor system which led to persistent deformities

Hemiplegic cerebral palsy patients:


* Structural deformities of the spine
* Any previous surgical and casting treatments as well as botulinumtoxin treatments within preceding 6 months.
* Obesity (\> 95th BMI-per-age percentile)
* Injuries of the locomotor system which led to persistent deformities

Diplegic cerebral palsy patients:


* Structural deformities of the spine
* Any previous surgical and casting treatments as well as botulinumtoxin treatments within preceding 6 months.
* Obesity (\> 95th BMI-per-age percentile)
* Injuries of the locomotor system which led to persistent deformities
Minimum Eligible Age

10 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Federal Institute of Technology

OTHER

Sponsor Role collaborator

Bern University of Applied Sciences

OTHER

Sponsor Role collaborator

University Children's Hospital Basel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Reinald Brunner, MD

Doctor in Charge, Neuro-Orthopedics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Reinald Brunner, MD

Role: PRINCIPAL_INVESTIGATOR

University Children's Hospital Basel

Stefan Schmid, PT, PhD

Role: STUDY_CHAIR

Swiss Federal Institute of Technology / Bern University of Applied Sciences

Silvio Lorenzetti, PhD, DSc

Role: STUDY_DIRECTOR

Swiss Federal Institute of Technology

Jacqueline Romkes, PhD

Role: STUDY_DIRECTOR

University Children's Hospital Basel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Children's Hospital Basel

Basel, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Schmid S, Romkes J, Taylor WR, Lorenzetti S, Brunner R. Orthotic correction of lower limb function during gait does not immediately influence spinal kinematics in spastic hemiplegic cerebral palsy. Gait Posture. 2016 Sep;49:457-462. doi: 10.1016/j.gaitpost.2016.08.013. Epub 2016 Aug 12.

Reference Type RESULT
PMID: 27543740 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UKBB-Spine-1315-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

enGIneering For sporT for All
NCT04794114 COMPLETED NA